Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Sustainability
The Rise of ESG: Where It Is Now and How It Got Here
Calls for corporate reform are as old as the corporation itself, so why now are companies pushing for more ESG efforts in their organizations?
By
Ted Jackson
| July 5, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Valeant
Risk & Compliance
Regulator Bars Valeant Officers From Trading
A Canadian regulator issues a cease trade order after the troubled drug maker announces it would be late filing financial reports.
By
Katie Kuehner-Hebert
| April 1, 2016
Read More
Risk & Compliance
Ex-Valeant CFO Denies ‘Improper Conduct’
Howard Schiller says he is not to blame for the incorrect recognition of $58 million in revenue that has caused Valeant to restate its financial results.
By
Katie Kuehner-Hebert
| March 21, 2016
Read More
Regulation
Valeant Discloses SEC Probe
The pharmaceuticals company also canceled its 2016 financial guidance and delayed filing its fourth-quarter earnings report.
By
Matthew Heller
| March 1, 2016
Read More
M&A
Roll-ups: Serial Thrillers
The agonies and ecstasies of firms that are addicted to doing takeovers.
By
Economist Staff
| December 21, 2015
Read More
Risk
Ackman’s Allergan Takeover Bid Is Easier Said Than Done
The takeover contest's outcome becomes unclear when we consider the conflict between the hedge fund’s objectives and the Allergan board's fiduciary duty.
By
Gardner Davis
| June 16, 2014
Read More
